4%) i trombocyttal hos lasofoxifenbehandlede patienter i PEARL- studiet.
As observed with other Selective Estrogen Receptor Modulators (SERMs), slightly decreased (approximately 4%) platelet counts were observed in lasofoxifene-treated patients in PEARL.